Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 14, 2016 09:30 ET | Source: Hagens Berman Sobol Shapiro LLP

LIGAND PHARMACEUTICALS INVESTOR REMINDER: Hagens Berman Reminds Ligand Pharmaceuticals Investors of Securities Class Action Lead Plaintiff Deadline

SAN FRANCISCO, Dec. 14, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) of the January 17, 2017 Lead Plaintiff deadline. ...
November 23, 2016 09:30 ET | Source: Hagens Berman Sobol Shapiro LLP

LIGAND PHARMACEUTICALS INVESTOR ALERT: Hagens Berman Alerts Ligand Pharmaceuticals Investors to Accounting Restatements, Securities Class Action, and Lead Plaintiff Deadline

SAN FRANCISCO, Nov. 23, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) to the securities class action filed in the U.S....